Astrazeneca (AZN) Dividends Paid - Common (2009 - 2026)
Astrazeneca (AZN) posted quarterly Dividends Paid - Common of $6.6 billion for Q2 2026, down 1.92% year-over-year from $6.7 billion in Q2 2025, and up 300.03% quarter-over-quarter from -$3.3 billion in Q1 2026.
Astrazeneca (AZN) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Astrazeneca's Dividends Paid - Common history runs 17 years deep, the most recent figure standing at $6.6 billion for Q2 2026.
- In Q2 2026, Dividends Paid - Common fell 1.92% year-over-year to $6.6 billion; the TTM figure through Jun 2026 stood at $4.9 billion (down 55.58% YoY), while the FY2025 annual figure was $5.0 billion, up 7.39% from the prior year.
- Dividends Paid - Common for Q2 2026 stood at $6.6 billion, up from -$3.3 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was $9.9 billion in Q4 2025, with the low at -$8.3 billion in Q3 2025.
- The 5-year median for Dividends Paid - Common is -$1.6 billion (2024), against an average of $526.8 million.
- Peak annual rise in Dividends Paid - Common reached 39535.29% in 2025, while the deepest fall reached 428.24% in 2025.
- Astrazeneca's Dividends Paid - Common stood at -$3.0 billion in 2022, then surged by 99.26% to -$22.0 million in 2023, then soared by 42168.18% to $9.3 billion in 2024, then advanced by 7.39% to $9.9 billion in 2025, then slumped by 33.85% to $6.6 billion in 2026.
- Business Quant data shows AZN's Dividends Paid - Common at $6.6 billion in Q2 2026, -$3.3 billion in Q1 2026, and $9.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.58 Bn |
| Jun 30, 2026 | 6.58 Bn |
| Mar 31, 2026 | -3.29 Bn |
| Mar 31, 2026 | -3.29 Bn |
| Dec 31, 2025 | 9.94 Bn |
| Dec 31, 2025 | 9.94 Bn |
| Sep 30, 2025 | -8.33 Bn |
| Sep 30, 2025 | -8.33 Bn |
| Jun 30, 2025 | 6.70 Bn |
| Jun 30, 2025 | 6.70 Bn |
| Mar 31, 2025 | -3.35 Bn |
| Mar 31, 2025 | -3.35 Bn |
| Dec 31, 2024 | 9.26 Bn |
| Dec 31, 2024 | 9.26 Bn |
| Sep 30, 2024 | -1.58 Bn |
| Sep 30, 2024 | -1.58 Bn |
| Jun 30, 2024 | -17.00 Mn |
| Jun 30, 2024 | -17.00 Mn |
| Mar 31, 2024 | -3.03 Bn |
| Mar 31, 2024 | -3.03 Bn |